Latest Ratios: P/E Ratio -4.2x · EV/EBITDA N/A · ROE -8.1%. (2008–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $181M | $252M | $454M | $252M | $209M | $283M | $244M | $333M | $400M | $334M | $279M |
| Enterprise Value | $254M | $325M | $495M | $293M | $314M | $416M | $370M | $441M | $479M | $439M | $370M |
| P/E Ratio → | -4.21 | — | 64.10 | 28.58 | — | — | — | — | 19.72 | 55.60 | 37.87 |
| P/S Ratio | 1.40 | 1.58 | 2.37 | 1.40 | 1.13 | 1.71 | 1.48 | 1.94 | 3.09 | 2.76 | 2.50 |
| P/B Ratio | 0.93 | 1.32 | 2.24 | 1.25 | 1.09 | 1.42 | 1.18 | 1.43 | 1.74 | 2.26 | 2.01 |
| P/FCF | — | — | 53.82 | — | 43.86 | — | — | — | — | 59.89 | — |
| P/OCF | — | — | 25.44 | — | 14.09 | 29.48 | — | 243.67 | 21.72 | 18.09 | 19.50 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.03 | 2.58 | 1.63 | 1.70 | 2.50 | 2.25 | 2.57 | 3.70 | 3.62 | 3.31 |
| EV / EBITDA | — | — | 225.37 | 15.16 | 41.86 | 115.82 | — | 215.08 | 28.58 | 23.94 | 25.44 |
| EV / EBIT | — | — | 39.57 | 21.17 | 118.89 | — | — | — | 32.35 | 36.62 | 25.08 |
| EV / FCF | — | — | 58.64 | — | 65.89 | — | — | — | — | 78.64 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -0.3% | -0.3% | 11.2% | 3.4% | 10.6% | 8.0% | 1.7% | 8.5% | 20.9% | 21.4% | 20.1% |
| Operating Margin | -15.1% | -15.1% | -3.2% | 6.0% | -1.2% | -3.7% | -11.2% | -3.8% | 7.3% | 9.8% | 8.2% |
| Net Profit Margin | -10.0% | -10.0% | 4.0% | 5.2% | -0.3% | -2.3% | -10.9% | -3.2% | 15.6% | 5.4% | 7.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -8.1% | -8.1% | 3.8% | 4.8% | -0.2% | -1.9% | -8.2% | -2.4% | 10.7% | 4.6% | 5.9% |
| ROA | -5.2% | -5.2% | 2.6% | 2.8% | -0.1% | -1.0% | -4.5% | -1.3% | 5.3% | 2.0% | 2.8% |
| ROIC | -7.1% | -7.1% | -1.9% | 3.0% | -0.5% | -1.4% | -4.1% | -1.5% | 2.5% | 3.7% | 3.0% |
| ROCE | -8.7% | -8.7% | -2.3% | 3.6% | -0.7% | -1.7% | -5.1% | -1.7% | 2.7% | 4.0% | 3.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.39 | 0.39 | 0.22 | 0.23 | 0.55 | 0.67 | 0.61 | 0.47 | 0.35 | 0.71 | 0.65 |
| Debt / EBITDA | — | — | 19.90 | 2.35 | 14.11 | 37.02 | — | 53.13 | 4.78 | 5.73 | 6.24 |
| Net Debt / Equity | — | 0.38 | 0.20 | 0.21 | 0.55 | 0.66 | 0.61 | 0.47 | 0.35 | 0.71 | 0.65 |
| Net Debt / EBITDA | — | — | 18.54 | 2.16 | 14.00 | 36.90 | — | 52.83 | 4.74 | 5.71 | 6.24 |
| Debt / FCF | — | — | 4.82 | — | 22.03 | — | — | — | — | 18.75 | — |
| Interest Coverage | -12.53 | -12.53 | 13.02 | 28.05 | 1.15 | -1.77 | -11.91 | -1.89 | 13.20 | 6.74 | 10.29 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.35 | 1.35 | 0.74 | 0.91 | 0.96 | 1.19 | 1.35 | 1.11 | 1.15 | 0.98 | 0.78 |
| Quick Ratio | 1.35 | 1.35 | 0.74 | 0.76 | 0.63 | 0.91 | 1.01 | 0.74 | 0.86 | 0.80 | 0.62 |
| Cash Ratio | 0.05 | 0.05 | 0.09 | 0.11 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 |
| Asset Turnover | — | 0.50 | 0.64 | 0.60 | 0.50 | 0.42 | 0.42 | 0.43 | 0.31 | 0.36 | 0.37 |
| Inventory Turnover | — | — | — | 36.26 | 12.91 | 15.25 | 15.19 | 13.53 | 13.23 | 23.13 | 23.23 |
| Days Sales Outstanding | — | 46.50 | 33.23 | 35.93 | 39.57 | 38.44 | 36.07 | 41.01 | 48.78 | 34.67 | 39.53 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.0% | 2.1% | 1.2% | 2.1% | 2.5% | 1.9% | 2.2% | 1.6% | 1.0% | 0.9% | 1.0% |
| Payout Ratio | — | — | 70.1% | 57.3% | — | — | — | — | 19.9% | 47.8% | 35.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 1.6% | 3.5% | — | — | — | — | 5.1% | 1.8% | 2.6% |
| FCF Yield | — | — | 1.9% | — | 2.3% | — | — | — | — | 1.7% | — |
| Buyback Yield | 0.0% | 0.0% | 0.5% | 0.2% | 0.7% | 0.2% | 1.5% | 0.2% | 0.0% | 0.1% | 100.0% |
| Total Shareholder Yield | 3.0% | 2.1% | 1.7% | 2.4% | 3.3% | 2.1% | 3.7% | 1.8% | 1.0% | 1.0% | 100.0% |
| Shares Outstanding | — | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $16M | $14M | $14M |
Includes 30+ ratios · 18 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LMNR stock.
Limoneira Company's current P/E ratio is -4.2x. The historical average is 60.0x.
Limoneira Company's return on equity (ROE) is -8.1%. The historical average is 2.0%.
Based on historical data, Limoneira Company is trading at a P/E of -4.2x. Compare with industry peers and growth rates for a complete picture.
Limoneira Company's current dividend yield is 3.05%.
Limoneira Company has -0.3% gross margin and -15.1% operating margin.
Key Metrics
Top Statement Risk
Rapid leverage against negative free cash flow
Metrics are mathematically derived from official filings.
Margin Swings Mask True Earning Power
Gross margin swung from 26.3% in 2024Q3 to -33.6% in 2026Q1 before recovering to 12.1% in 2026Q3, while operating margin was negative in eight of the last nine quarters, according to Limoneira's quarterly filings, pointing to cost absorption weakness rather than one-off noise.
The 2026Q2 divergence between a -19.0% operating margin and a -89.5% net margin suggests material below-the-line items amplified the loss, so adjusted operating margin likely overstates nothing while net margin overstates the run-rate damage; investors should treat neither as clean earning power. Operating margin, not net margin, is the more defensible yardstick here because it strips those non-operating swings, and at 3.4% in 2026Q3 it still sits roughly 11 points below the 14.2% posted in 2024Q3, implying the orchid-to-harvest cost base has not scaled down with revenue. Free cash flow margin of -8.8% in 2026Q3 confirms that reported operating improvement has not yet converted into cash.
Invested Capital Earns Nothing
ROIC turned negative after 2024Q3 and has not exceeded 0.4% since, bottoming at -4.9% in 2025Q4 versus 2.6% in 2024Q3, per Limoneira's reported figures, suggesting capital tied up in orchards and packing assets is generating essentially no economic return during the downturn.
The decay appears driven by margin compression rather than asset efficiency: asset turnover slipped from 0.20 in 2024Q3 to 0.15 in 2026Q3 while ROIC fell far more sharply, meaning the return shortfall is primarily a pricing and cost-absorption problem, not a utilization collapse. ROE of -1.8% in 2026Q3 against ROIC of 0.4% shows leverage is currently diluting rather than boosting shareholder returns, a reversal from the modest positive spread in 2024Q3. Compared with peers reporting ROIC of 6.7% to 8.6%, the gap looks structural for as long as harvest volumes and realized prices remain below the 2024 peak, and investors should monitor whether ROIC can be restored to a positive double-digit level before the asset base is judged to be compounding value.
Debt Surge Squeezes Coverage Rapidly
Total debt climbed from roughly zero in 2025Q3 to $109.0M by 2026Q3, lifting debt-to-equity from 0.00 to 0.68 in four quarters, as Limoneira's balance sheet shows interest coverage of just 1.35x versus a 34.8x level in 2024Q3.
Coverage has moved from comfortably positive to barely above 1x while several intermediate quarters printed negative coverage on operating losses, which suggests debt service capacity now rests almost entirely on recovering harvest profitability rather than on existing earnings. The pace of re-leveraging, with D/E rising from 0.00 to 0.68 in a single year against a free cash flow burn of $26.3M cumulatively, appears necessity-driven rather than opportunistic, so refinancing terms and covenant headroom warrant close attention. At 31.57x D/EBITDA in 2026Q3 versus 3.97x in 2024Q3, the leverage multiple is well beyond levels typical for the sector and implies limited margin for another poor crop cycle.
Headline Current Ratio Overstates Cushion
Current and quick ratios both stood at 1.51 in 2026Q3, yet Limoneira reported only $2.2M of cash against $109.0M of debt, according to its quarterly balance sheet, suggesting the headline ratio is supported by working-capital balances rather than a spendable buffer.
The current ratio actually improved from 0.74 in 2024Q4 to 1.51 in 2026Q3 even as equity fell and losses mounted, which implies the improvement reflects liability reclassification or drawdown timing rather than genuine strengthening of the asset side. Quick matching current in every recent quarter indicates inventory is not the swing factor, but with DSO widening to 101 days in 2026Q1 before settling at 34 days in 2026Q3, receivable seasonality appears to be the real driver of reported liquidity. Under a stress scenario of another loss-making quarter combined with the observed $11.2M of dividends paid over ten quarters, the $2.2M cash position would leave little room without additional borrowing, so the liquidity profile should be judged as thin despite the ratio above 1.
Book Multiple Reflects Erosion, Not Value
Limoneira trades at 1.03x book and 1.25x sales while trailing P/E sits at -11.80, per current market multiples, a level below Calavo at 2.24x book and Mission Produce at 1.33x that appears to price loss-making operations rather than genuine asset value.
With EV/EBITDA and forward P/E unavailable in the supplied data, book and sales multiples carry the valuation argument, and 1.03x book looks optically cheap only against a book base that shrank from $192.0M to $142.8M over seven quarters as losses accumulated. Relative to peers reporting positive ROE of 4.0% to 7.8%, LMNR's negative ROE means its lower P/B is consistent with its return profile rather than a dislocation, so the discount may be rational rather than an opportunity. The 2.8% dividend yield, paid out of $11.2M of distributions against -$26.3M of cumulative free cash flow, warrants scrutiny as a use of borrowed capital rather than a sign of cash-generating strength.
The P/E Trap in Cyclic Growers
A trailing P/E of -11.80 offers no signal for Limoneira, whose net margin swung between -89.5% and 14.7% across ten quarters, per current market multiples, making normalized EV/EBITDA or asset-based valuation the more defensible lens for a cyclical grower.
For a grower whose earnings are dictated by harvest timing, weather, and commodity pricing, P/E misapplies because a single depressed or inflated earnings year mechanically drives the multiple to nonsense, obscuring the underlying value of long-lived orchard acreage. What the P/E obscures here is that asset turnover of just 0.15 and ROIC near zero mean the valuation question is really about land and tree productivity, not near-term earnings. Investors should instead triangulate on normalized EV/EBITDA across a full crop cycle, which is unavailable in the supplied data, and on book value adjusted for the apparent $33.3M reduction in net property, plant, and equipment between 2026Q1 and 2026Q3, which itself warrants further investigation before 1.03x book can be called cheap.